SINOQUAL Assists Xinxiang Ruicheng Technology Nucleoside APIs in Obtaining Indonesian BPJPH Halal Certification

Xinxiang Ruicheng Technology specializes in the production of nucleoside-class active pharmaceutical ingredients (APIs). Nucleosides are fundamental building blocks used in antiviral and anticancer drug manufacturing.

With the approach of Indonesia mandatory Halal certification deadline for pharmaceutical products, Xinxiang Ruicheng chose SINOQUAL to obtain BPJPH Halal certification for its nucleoside API products. This ensures the company can continue supplying Indonesian pharmaceutical manufacturers.

SINOQUAL provided specialized pharmaceutical API certification guidance, covering raw material sourcing verification, synthesis process review, and factory audit coordination.

Xinxiang Ruicheng Technology Nucleoside APIs Obtain Indonesian BPJPH Halal Certification
Xinxiang Ruicheng Technology Nucleoside APIs Obtain Indonesian BPJPH Halal Certification

FAQ

What pharmaceutical products were certified?
Xinxiang Ruicheng Technology obtained Indonesian BPJPH Halal certification for its nucleoside-class API products with SINOQUAL assistance. Nucleosides are used in antiviral and anticancer drug manufacturing.
Why do pharmaceutical APIs need Indonesian Halal certification?
Indonesia is implementing mandatory Halal certification for pharmaceutical products (effective October 2026). API suppliers must obtain certification to continue supplying Indonesian pharmaceutical manufacturers.